In this context it should also be underlined that cancer mutants in the molecular switch residues R6×32 and W7×55, which for example render SMO a tumor driver, could act oncogenic in FZDs by switching FZDs from DVL to G protein coupling as previously surmised17. The gene discussed is SMO; the disease is cancer.